|
Regeneron's New Asthma Drug And Its Fierce Competitors
Seeking Alpha There are a large variety of asthma drugs on the market, but the most they can do is alleviate symptoms. They do little about the substance of the disease. Dupilumab, an injectable medication being developed by Regeneron Pharmaceuticals (REGN) and … |
View full post on asthma – Google News